Hyperglykemia äkillisissä keuhkosairauksissa

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-002798-38-FI

Enrollment

320

Registered

2006-05-19

Start date

2006-11-03

Completion date

Unknown

Last updated

2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

potilailla,joilla on keukokuume tai astman/keuhkoahtautuman pahenemisvaihe ja sen yhteydessä hyperglykemiaa

Interventions

Trade Name: Novomix Product Name: Novomix Pharmaceutical Form: Solution for injection INN or Proposed INN: Aspartinsuliini

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: potilailla,joilla on keukokuume tai astman/keuhkoahtautuman pahenemisvaihe ja sen yhteydessä hyperglykemiaa;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026